771
Views
42
CrossRef citations to date
0
Altmetric
Review

Epidemiology of Atypical Hemolytic Uremic Syndrome: A Systematic Literature Review

, , ORCID Icon, & ORCID Icon
Pages 295-305 | Published online: 12 Mar 2020

References

  • Raina R, Krishnappa V, Blaha T, et al. Atypical hemolytic-uremic syndrome: an update on pathophysiology, diagnosis, and treatment. Ther Apher Dial. 2019;23(1):4–21. doi:10.1111/tap.2019.23.issue-130294946
  • Yoshida Y, Kato H, Ikeda Y, Nangaku M. Pathogenesis of atypical hemolytic uremic syndrome. J Atheroscler Thromb. 2019;26(2):99–110. doi:10.5551/jat.RV1702630393246
  • Noris M, Remuzzi G. Hemolytic uremic syndrome. J Am Soc Nephrol. 2005;16(4):1035. doi:10.1681/ASN.200410086115728781
  • Loirat C, Frémeaux-Bacchi V. Atypical hemolytic uremic syndrome. Orphanet J Rare Dis. 2011;6:60. doi:10.1186/1750-1172-6-6021902819
  • Zhang K, Lu Y, Harley KT, Tran M-H. Atypical hemolytic uremic syndrome: a brief review. Hematol Rep. 2017;9(2):7053. doi:10.4081/hr.2017.705328626544
  • Noris M, Remuzzi G. Atypical hemolytic–uremic syndrome. N Engl J Med. 2009;361(17):1676–1687. doi:10.1056/NEJMra090281419846853
  • Sridharan M, Go RS, Willrich MAV. Atypical hemolytic uremic syndrome: review of clinical presentation, diagnosis and management. J Immunol Methods. 2018;461:15–22. doi:10.1016/j.jim.2018.07.00630031798
  • Fakhouri F, Zuber J, Frémeaux-Bacchi V, Loirat C. Haemolytic uraemic syndrome. Lancet. 2017;390(10095):681–696. doi:10.1016/S0140-6736(17)30062-428242109
  • Goodship THJ, Cook HT, Fakhouri F, et al. Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) controversies conference. Kidney Int. 2017;91(3):539–551. doi:10.1016/j.kint.2016.10.00527989322
  • Disorders NOfR. Atypical hemolytic uremic syndrome. 2019 Available from: https://rarediseases.org/rare-diseases/atypical-hemolytic-uremic-syndrome/. Accessed 33, 2020.
  • Roumenina LT, Loirat C, Dragon-Durey M-A, Halbwachs-Mecarelli L, Sautes-Fridman C, Fremeaux-Bacchi V. Alternative complement pathway assessment in patients with atypical HUS. J Immunol Methods. 2011;365(1):8–26.21215749
  • Noris M, Caprioli J, Bresin E, et al. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol. 2010;5(10):1844. doi:10.2215/CJN.0221031020595690
  • Fremeaux-Bacchi V, Fakhouri F, Garnier A, et al. Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide french series comparing children and adults. Clin J Am Soc Nephrol. 2013;8(4):554–562. doi:10.2215/CJN.0476051223307876
  • Kaplan BS, Ruebner RL, Spinale JM, Copelovitch L. Current treatment of atypical hemolytic uremic syndrome. Intractable Rare Dis Res. 2014;3(2):34–45. doi:10.5582/irdr.2014.0100125343125
  • Schaefer F, Ardissino G, Ariceta G, et al. Clinical and genetic predictors of atypical hemolytic uremic syndrome phenotype and outcome. Kidney Int. 2018;94(2):408–418. doi:10.1016/j.kint.2018.02.02929907460
  • Yoshida Y, Kato H, Nangaku M. Atypical hemolytic uremic syndrome. Ren Replace Ther. 2017;3(1):5. doi:10.1186/s41100-016-0088-1
  • Al-Eisa A, Al-Hajeri M. Hemolytic uremic syndrome in Kuwaiti Arab children. Pediatr Nephrol. 2001;16(12):1093–1098. doi:10.1007/s00467010003611793108
  • Schifferli A, von Vigier RO, Fontana M, et al. Hemolytic-uremic syndrome in Switzerland: a nationwide surveillance 1997–2003. Eur J Pediatr. 2010;169(5):591–598. doi:10.1007/s00431-009-1079-919830454
  • Elliott EJ, Robins-Browne RM, Loughlin EV, et al. Nationwide study of haemolytic uraemic syndrome: clinical, microbiological, and epidemiological features. Arch Dis Child. 2001;85(2):125. doi:10.1136/adc.85.2.12511466187
  • Laurence J. Atypical Hemolytic Uremic Syndrome (aHUS): making the diagnosis. Clin Adv Hematol Oncol. 2012;10:10.
  • Quality assessment tool for observational cohort and cross-sectional studies. Study Quality Assessment Tools. 2019 Available from: https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools. Accessed 33, 2020.
  • Moher D, Liberati A, Tetzlaff J, Altman DG, The PG. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi:10.1371/journal.pmed.100009719621072
  • Zimmerhackl LB, Besbas N, Jungraithmayr T, et al. Epidemiology, clinical presentation, and pathophysiology of atypical and recurrent hemolytic uremic syndrome. Semin Thromb Hemost. 2006;32(2):113–120. doi:10.1055/s-2006-93976716575686
  • Bayer G, Von Tokarski F, Thoreau B, et al. Etiology and outcomes of thrombotic microangiopathies. Clin J Am Soc Nephrol. 2019;14(4):557–566. doi:10.2215/CJN.1147091830862697
  • Ardissino G, Salardi S, Colombo E, et al. Epidemiology of haemolytic uremic syndrome in children. Data from the North Italian HUS network. Eur J Paediatr. 2016;175(4):465–473. doi:10.1007/s00431-015-2642-1
  • Jenssen GR, Hovland E, Bjerre A, Bangstad HJ, Nygard K, Vold L. Incidence and etiology of hemolytic-uremic syndrome in children in Norway, 1999–2008 - a retrospective study of hospital records to assess the sensitivity of surveillance. BMC Infect Dis. 2014;14(1). doi:10.1186/1471-2334-14-265
  • Wuhl E, Van Stralen KJ, Wanner C, et al. Renal replacement therapy for rare diseases affecting the kidney: an analysis of the ERA-EDTA registry. Nephrol Dial Transpl. 2014;29(Supplement4):iv1–iv8. doi:10.1093/ndt/gfu030
  • Durkan AM, Kim S, Craig J, Elliott E. The long-term outcomes of atypical haemolytic uraemic syndrome: a national surveillance study. Arch Dis Child. 2016;101(4):387–391. doi:10.1136/archdischild-2015-30947126729748
  • Mallett A, Patel C, Salisbury A, Wang Z, Healy H, Hoy W. The prevalence and epidemiology of genetic renal disease amongst adults with chronic kidney disease in Australia. Orphanet J Rare Dis. 2014;9(1):98. doi:10.1186/1750-1172-9-9824980890
  • Hooman N, Sadeghian M, Jahangiri F, Hosseini S. The prevalence and incidence of atypical hemolytic uremic syndrome in Iran: a systematic review and Meta-Analysis Protocol Study. J Compr Ped. 2018;9(1):e56080.
  • Chang H-GH, Tserenpuntsag B, Kacica M, Smith PF, Morse DL. Hemolytic uremic syndrome incidence in New York. Emerg Infect Dis. 2004;10(5):928–931. doi:10.3201/eid1005.03045615200834
  • Proulx F, Sockett P. Prospective surveillance of Canadian children with the haemolytic uraemic syndrome. Pediatr Nephrol. 2005;20(6):786–790. doi:10.1007/s00467-005-1843-715834619
  • Terrell DR, Williams LA, Vesely SK, Lämmle B, Hovinga JAK, George JN. The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency. J Thromb Haemost. 2005;3(7):1432–1436. doi:10.1111/jth.2005.3.issue-715978100
  • Constantinescu AR, Bitzan M, Weiss LS, et al. Non-enteropathic hemolytic uremic syndrome: causes and short-term course. Am J Kidney Dis. 2004;43(6):976–982. doi:10.1053/j.ajkd.2004.02.01015168377
  • Berger BE. Atypical hemolytic uremic syndrome: a syndrome in need of clarity. Clin Kidney J. 2018;12(3):338–347. doi:10.1093/ckj/sfy06631198222
  • Copelovitch L, Kaplan BS. Streptococcus pneumoniae–associated hemolytic uremic syndrome: classification and the emergence of serotype 19A. Pediatrics. 2010;125(1):e174. doi:10.1542/peds.2007-201720026500